The Scion NeuroStim website lists 21 patents and states that other patents are pending in the U.S. and internationally. The company has raised $10 million for its research efforts.
Osteoarthritis (OA) of the knee is the most common form of arthritis, affecting 30 million Americans and 500 million globally. There are currently no drugs or other treatments available for OA.
QuadVantage was created to address ACL reconstruction needs identified by founder and Chief Medical Officer, Dr. Paul Burroughs, MD.
DURHAM — Levee Medical, Inc. last week filed with the SEC for their second major round of funding. According to the document the company has raised more than $3.4 million in debt from 34 investors. The company aims to raise a total of $4.3 million, with more than $850,000 remaining. Levee Medical is focused on … Read More
Sean Ekins and Fabio Urbina, two Collaborations scientists, decided to tweak their drug discovery platform to see what results they might produce. The platform was reprogramed to generate VX, one of the deadliest and fastest-acting chemical warfare nerve agents.
The company is working towards FDA approval of its epinephrine nasal spray, named UTULY, for treating anaphylaxis. If successful, it may replace the current anaphylaxis treatment standard, which is the needle-based EPIPEN.
“We will be one of the best places to work in this industry,” Fortrea CEO Tom Pike says in a briefing about the spinoff from global life science giant Labcorp. Here’s what he wants – a “magnet” workforce to win customers. And much more.
Keona Health last week disclosed its largest-ever public disclosure of funds, an equity investment of more than $4.6 million. The company last took on debt funding totaling $750,000 in 2021.
“[As women,] it’s in our biology to seek community and rely on community. In many cultures, menopausal women getting together is part of the culture, right? They’re seen in some cultures as the wisest humans that should be trusted and leaned on and respected. We don’t do a very good job of that in America.” So says femtech thought leader Brittany Barreto.
STARTUP SPOTLIGHT: Alzheimer’s Disease and dementia have long been feared by many, especially those with first-hand experience. Raleigh-based uMETHOD is working with global giant Quest Diagnostics to help address those fears driven in part by the experiences of its company founder who says the issues are “personal to me.”
© Marit Digital, LLC 2026 | Privacy Policy | AI Policy | Code of Conduct | Impact Report
© Marit Digital, LLC 2025 | Privacy Policy | AI Policy | Code of Conduct | Impact Report